U.S. FDA approval, insurance coverage and indication expansion for medical devices

An initiative that starts with obtaining FDA approval for medical devices in the United States, advances insurance coverage, and expands indications and eligible patients to include cerebral palsy, HAM and hereditary spastic paraplegia. It also includes developing the business in the United States after approval.